187 related articles for article (PubMed ID: 32815623)
1. HCV micro-elimination in two prisons in Milan, Italy: A model of care.
Giuliani R; Casigliani V; Fornili M; Sebastiani T; Freo E; Arzilli G; Scardina G; Baglietto L; Tavoschi L; Ranieri R
J Viral Hepat; 2020 Dec; 27(12):1444-1454. PubMed ID: 32815623
[TBL] [Abstract][Full Text] [Related]
2. Solving the Gap Between HCV Detection and Treatment in Prison HCVRNA Testing and Treatment in a Cohort of Newly Arrived Convicts in Southern Italy.
Izzo C; Masarone M; Torre P; Melara G; De Matteis G; De Luna A; Pagano AM; Persico M
Rev Recent Clin Trials; 2021; 16(4):396-402. PubMed ID: 34126911
[TBL] [Abstract][Full Text] [Related]
3. Impact of 5 years of hepatitis C testing and treatment in the North East of England prisons.
Johnson A; Shearer J; Thompson C; Jelley R; Aldridge J; Allsop C; Kerry J; Jones D; McCullough F; Miller C; Valappil M; Taha Y; Masson S; Jefferson T; Lawton C; Christensen L; McPherson S
J Viral Hepat; 2023 Dec; 30(12):914-921. PubMed ID: 37700492
[TBL] [Abstract][Full Text] [Related]
4. [HIVAb, HCVAb and HBsAg seroprevalence among inmates of the prison of Bologna and the effect of counselling on the compliance of proposed tests].
Sabbatani S; Giuliani R; Fulgaro C; Paolillo P; Baldi E; Chiodo F
Epidemiol Prev; 2004; 28(3):163-8. PubMed ID: 15532873
[TBL] [Abstract][Full Text] [Related]
5. [Seroprevalence of hepatitis C virus infection at the time of entry to prison in the prison population in the north-east of Spain].
Martín Sánchez V; Ferrer Castro V; Pallas Álvarez JR; Alonso Herrero LE; Andrés Honorato M; Coterillo González MJ; García Marcos LS; González Márquez J; Hernández Alonso I; LLanos Gallegos M; Mallada García E; Martínez Martínez ML; Morillo Pérez M; Pérez Martínez I; Valles Martínez J
Rev Esp Salud Publica; 1998; 72(1):43-51. PubMed ID: 9477715
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C Virus Elimination Program among Prison Inmates, Israel.
Eisen L; Mor Z; Madar M; Rabinovitch R; Dadon Y; Sheffer R; Kaliner E; Goldstein L
Emerg Infect Dis; 2023 Nov; 29(11):2358-2361. PubMed ID: 37877627
[TBL] [Abstract][Full Text] [Related]
7. HCV spread among female incarcerated population and treatment pathways to viral elimination in Italian prison settings: clinical perspectives and medico legal aspects.
Fiore V; Rastrelli E; Madeddu G; Ranieri R; De Vito A; Giuliani R; Di Mizio G; Bolcato M; De Matteis G; Ialungo AM; Dell'Isola S; Starnini G; Babudieri S
BMC Infect Dis; 2022 Jul; 22(1):601. PubMed ID: 35799126
[TBL] [Abstract][Full Text] [Related]
8. Chronic Hepatitis C Cascade of Care in Prisoners-Is There Still Some Work to Do? Analysis of Two Large Penitentiaries in Northern Italy.
Cambianica A; Marchese V; Pennati F; Faustinelli A; Migliorati M; Roda F; Spinetti A; Zaltron S; Fiorentini S; Caruso A; Quiros-Roldan E; Castelli F; Focà E
Int J Environ Res Public Health; 2024 Jan; 21(1):. PubMed ID: 38248566
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting.
Brandolini M; Novati S; De Silvestri A; Tinelli C; Patruno SF; Ranieri R; Seminari E
BMC Public Health; 2013 Oct; 13():981. PubMed ID: 24139133
[TBL] [Abstract][Full Text] [Related]
10. Development and optimisation of a reception testing protocol designed to eliminate HCV in the UK prison population.
Mongale E; Allen S; Brew I; Ludlow-Rhodes A; Royal N; Waldron J; Alexander H; Christensen L; Dorrington K; Milner A; Missen L; Jones A; Troke PJF
JHEP Rep; 2024 Jan; 6(1):100937. PubMed ID: 38169900
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program.
Masarone M; Caruso R; Aglitti A; Izzo C; De Matteis G; Attianese MR; Pagano AM; Persico M
Dig Liver Dis; 2020 May; 52(5):541-546. PubMed ID: 32234417
[TBL] [Abstract][Full Text] [Related]
12. Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine.
Morey S; Hamoodi A; Jones D; Young T; Thompson C; Dhuny J; Buchanan E; Miller C; Hewett M; Valappil M; Hunter E; McPherson S
J Viral Hepat; 2019 Jan; 26(1):101-108. PubMed ID: 30315691
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison.
Okafor IM; Ugwu SO; Okoroiwu HU
BMC Gastroenterol; 2020 Oct; 20(1):360. PubMed ID: 33126856
[TBL] [Abstract][Full Text] [Related]
14. Detection, stratification and treatment of hepatitis C-positive prisoners in the United Kingdom prison estate: Development of a pathway of care to facilitate the elimination of hepatitis C in a London prison.
Connoley D; Francis-Graham S; Storer M; Ekeke N; Smith C; Macdonald D; Rosenberg W
J Viral Hepat; 2020 Oct; 27(10):987-995. PubMed ID: 32449969
[TBL] [Abstract][Full Text] [Related]
15. The effect of direct-acting antiviral regimens and telemedicine on the treatment of inmates with hepatitis C virus infection in Israeli prisons.
Richter V; Goldstein L; Cohen DL; Bermont A; Zelnik Yovel D; Madar M; Rabinovitch R; Shirin H; Broide E
Sci Prog; 2022; 105(2):368504221105173. PubMed ID: 35722762
[TBL] [Abstract][Full Text] [Related]
16. Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.
Crowley D; Murtagh R; Cullen W; Keevans M; Laird E; McHugh T; McKiernan S; Miggin SJ; O'Connor E; O'Reilly D; Betts-Symonds G; Tobin C; Van Hout MC; Lambert JS
Harm Reduct J; 2019 Jul; 16(1):42. PubMed ID: 31277665
[TBL] [Abstract][Full Text] [Related]
17. HCV testing and treatment initiation in an Italian prison setting: A step-by-step model to micro-eliminate hepatitis C.
Fiore V; De Matteis G; Ranieri R; Saderi L; Pontali E; Muredda A; Ialungo AM; Caruso R; Madeddu G; Sotgiu G; Babudieri S
Int J Drug Policy; 2021 Apr; 90():103055. PubMed ID: 33310637
[TBL] [Abstract][Full Text] [Related]
18. The role of prison-based interventions for hepatitis C virus (HCV) micro-elimination among people who inject drugs in Montréal, Canada.
Godin A; Kronfli N; Cox J; Alary M; Maheu-Giroux M
Int J Drug Policy; 2021 Feb; 88():102738. PubMed ID: 32278651
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of hepatitis B and hepatitis C infections and their relationship to injectable drug use in a cohort of Sri Lankan prison inmates.
Niriella MA; Hapangama A; Luke HP; Pathmeswaran A; Kuruppuarachchi KA; de Silva HJ
Ceylon Med J; 2015 Mar; 60(1):18-20. PubMed ID: 25804913
[TBL] [Abstract][Full Text] [Related]
20. Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era.
Hariri S; Sharafi H; Sheikh M; Merat S; Hashemi F; Azimian F; Tamadoni B; Ramazani R; Gouya MM; Abbasi B; Tashakorian M; Alasvand R; Alavian SM; Poustchi H; Malekzadeh R
Harm Reduct J; 2020 Oct; 17(1):80. PubMed ID: 33081794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
